Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

953
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
953
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

308
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
308
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

536
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
536
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

131
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
131

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demystifying the Role of Histone Demethylases in Colorectal Cancer: Mechanisms and Therapeutic Opportunities.

Current issues in molecular biology·2025
Same author

The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis.

Journal of clinical and translational hepatology·2025
Same author

Causal Effects of Sleep Traits on Angina Pectoris: Mediation by Cardiovascular Risk Factors.

Nature and science of sleep·2025
Same author

EUS-guided cyanoacrylate glue injection for the management of refractory bleeding from postglue ulcer following gastric varices treatment (with video).

Endoscopic ultrasound·2025
Same author

Histone Methylation Regulation as a Potential Target for Non-alcoholic Fatty Liver Disease.

Current protein & peptide science·2023
Same author

Histone Demethylation Profiles in Nonalcoholic Fatty Liver Disease and Prognostic Values in Hepatocellular Carcinoma: A Bioinformatic Analysis.

Current issues in molecular biology·2023

Related Experiment Video

Updated: Sep 7, 2025

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
09:13

Development of a Larval Zebrafish Infection Model for Clostridioides difficile

Published on: February 14, 2020

6.5K

Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review.

Yuanbin Liu1, Mingkai Chen1

  • 1Department of Gastroenterology, Renmin Hospital of Wuhan University, No. 99 Zhang Zhidong Road, Wuhan 430000, Hubei, China.

Canadian Journal of Gastroenterology & Hepatology
|June 17, 2022
PubMed
Summary

Clostridioides difficile infection (CDI) is common in cirrhosis patients, with increasing prevalence but decreasing mortality. Rifaximin, lactulose, and fecal microbiota transplantation show promise for managing CDI in this population.

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K

Related Experiment Videos

Last Updated: Sep 7, 2025

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
09:13

Development of a Larval Zebrafish Infection Model for Clostridioides difficile

Published on: February 14, 2020

6.5K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Clostridioides difficile infection (CDI) is a significant nosocomial infection, renamed from Clostridium difficile in 2016.
  • CDI is prevalent in cirrhosis patients and adversely impacts prognosis.
  • Understanding CDI in cirrhosis is crucial for clinical practice.

Purpose of the Study:

  • To review the clinical implications of CDI in cirrhosis.
  • To summarize current knowledge on risk factors, treatment, and prevention.

Main Methods:

  • Literature review of studies on CDI in cirrhotic patients.
  • Analysis of risk factors, treatment efficacy, and prevention strategies.

Main Results:

  • CDI prevalence in cirrhosis is increasing, but mortality is decreasing.
  • Risk factors include antibiotic use, cirrhosis severity, comorbidities, and demographics.
  • Rifaximin and lactulose may reduce CDI risk; fecal microbiota transplantation shows safety and efficacy for recurrent CDI.

Conclusions:

  • CDI management in cirrhosis requires tailored approaches.
  • Further prospective studies are needed to validate treatment efficacy.
  • Prevention relies on strict hygiene and environmental cleaning, not widespread screening.